Ticker Details
Sutro Biopharma, Inc.
IPO Date:	October 12, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$301.86M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.47%
Avg Daily Range (30 D):	$0.68 | 4.59%
Avg Daily Range (90 D):	$0.37 | 4.78%

Institutional Daily Volume
Avg Daily Volume:	.17M
Avg Daily Volume (30 D):	.13M
Avg Daily Volume (90 D):	.12M

Trade Size
Avg Trade Size (Sh.):	47
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	39

Institutional Trades
Total Institutional Trades:	648
Avg Institutional Trade:	$1.62M
Avg Institutional Trade (30 D):	$.77M
Avg Institutional Trade (90 D):	$1.12M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.63M
Avg Closing Trade (30 D):	$.71M
Avg Closing Trade (90 D):	$.71M
Avg Closing Volume:	16.21K

News

Feb 10, 2026 @ 12:00 PM Sutro Biopharma Announces Pricing of $110.0 millio... Source: Na

Dec 3, 2025 @ 1:00 PM Sutro Biopharma Announces First Cohort of Patients... Source: Sutro Biopharma

Nov 12, 2025 @ 3:00 PM Sutro Biopharma Highlights Next-Generation ADC Inn... Source: Sutro Biopharma

Nov 3, 2025 @ 1:00 PM Sutro Biopharma Announces Participation at the 16t... Source: Sutro Biopharma

Aug 28, 2025 @ 2:44 PM FDA Tightens Survival Standards as Cancer Drug Pip... Source: Prnewswire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.6	$-.67	$-.14
Diluted EPS	$-2.6	$-.67	$-.14
Revenue	$105.65M	$9.69M	$63.75M
Gross Profit
Net Income / Loss	$-216.77M	$-56.86M	$-11.5M
Operating Income / Loss	$-185.58M	$-48.46M	$-3.35M
Cost of Revenue
Net Cash Flow	$-108.65M	$1.9M	$-42.2M
PE Ratio

Splits
Dec 03, 2025	1:10